dia 2022

Javara, CVS Health join Parexel’s clinical trial alliance group

By Jenni Spinner contact

- Last updated on GMT

(Pict Rider/iStock via Getty Images Plus)
(Pict Rider/iStock via Getty Images Plus)

Related tags: Javara, patient engagement, diversity, Patient centricity, Patient recruitment, Parexel

Parexel's Community Alliance Network, designed to more deeply integrate clinical research into community healthcare, has invited Javara and CVS as members

Contract research organization (CRO) Parexel has established its Community Alliance Network, a program geared toward further integrating clinical research into community healthcare. CVS Health and integrated research organization (IRO) Javara have signed onto the network as inaugural members.

For too long, clinical research has been siloed in small pockets of the healthcare system,​” said Clare Grace, chief patient officer at Parexel. “Not only has this slowed therapeutic innovation, but it also has limited patient access to clinical research as a care option. Providing patients more opportunities to access and participate in clinical research — through their physician’s office, in CVS MinuteClinics within designated HealthHUB locations, or through traditional academic sites or hospitals — is a critical and strategic decision. Parexel is leading the way in providing access to the 95% of patients who don’t currently participate in research to design clinical trials that revolve around the patient.​”

Over the last decade, Parexel has built its Site Alliance Network, which includes more than 500 clinical research institutions and 21,000 principal investigators across 20+ countries, with diverse site staff and patient populations across all therapeutic areas. According to the company, its Community Alliance Network builds on such efforts via partnerships with healthcare and research organizations with close relationships with and proximity to patients who previously had no or little ability to participate in clinical research.

“The traditional research delivery model does not effectively connect the majority of patients to clinical trial opportunities as part of a patient’s routine healthcare experience, and as a result, only a small percentage are currently aware of research as a potential care option​,” said Jennifer Byrne, Javara’s CEO. “Parexel’s Community Alliance Network aligns perfectly with Javara’s mission to advance access to clinical research as a care option by connecting with patients through the healthcare organizations and physicians they already know and trust.”

“It is a privilege to join this program as an inaugural member to further bridge the gap between clinical research and clinical care and bring trials to those who need them most​,” Byrne added.

“By joining the Community Alliance Network, we can continue to bring healthcare solutions to consumers within the communities where they live and work,​” said Tony Clapsis, senior vice president and general manager for CVS Health’s Clinical Trial Services. “With our community presence across the U.S., we’re able to accelerate access to clinical trials, and at the same time help to address longstanding issues with recruitment and diversity​.”

Javara, Parexel, and CVS Health are participating in the DIA Global Annual Meeting, taking place June 19-23 in Chicago. Read here for more information or to register for the event.

Related news

Show more

Related products

show more

ODM and CDASH in CRF design

ODM and CDASH in CRF design

Formedix | 15-Aug-2022 | Technical / White Paper

The lesser-known Operational Data Model (ODM) standard is often overlooked as it's not required by any regulators. So, why should you be interested...

dPCR Case Study

dPCR Case Study

CellCarta | 08-Aug-2022 | Case Study

Streamline your adoptive cell therapy program with digital PCR. Our team has a unique expertise in digital and quantitative PCR to support you in ensuring...

Related suppliers

Follow us

Products

View more

Webinars